Stock listing
Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A
Selected listing: 002262 · SZSE · CNY · CN
Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A (Shenzhen:002262), Health Technology. Latest release Apr 18, 2026: Jiangsu Nhwa Pharmaceutical: Revenue up…
- Ticker
- Shenzhen:002262
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Shenzhen
- Currency
- CNY
About Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A
Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A is a publicly traded company in China, listed under the ticker 002262. Jiangsu Nhwa focuses on the pharmaceutical industry, contributing to healthcare solutions in the region.
Latest news from Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A
Jiangsu Nhwa Pharmaceutical: Revenue up 3.75%, net profit down 7.54%, strong R&D and cash flow, dividend proposed
April 17, 2026
Jiangsu Nhwa Pharmaceutical Says 2025 Net Profit Down 7.5%
April 17, 2026
Jiangsu Nhwa Pharmaceutical: Q3 2025 revenue and net profit rose 5.70% and 3.67% year-over-year, respectively
October 25, 2025
Jiangsu Nhwa Pharmaceutical Q3 Net Profit Up 3.7% Y/Y
October 24, 2025
Jiangsu Nhwa Pharmaceutical: Net profit up 11.38% year-over-year, with strong CNS drug sales and R&D growth
July 29, 2025
Research Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A
Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A company profile
View the public company page for Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A on 6ix.
Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A news
Read company news and market updates connected to Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A.
Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A.